Published in Clin Exp Immunol on August 01, 2015
Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nat Med (2002) 10.03
Memory CD8+ T cell differentiation: initial antigen encounter triggers a developmental program in naïve cells. Nat Immunol (2001) 9.23
Naïve CTLs require a single brief period of antigenic stimulation for clonal expansion and differentiation. Nat Immunol (2001) 6.78
Signals required for programming effector and memory development by CD8+ T cells. Immunol Rev (2006) 4.60
Signal 3 determines tolerance versus full activation of naive CD8 T cells: dissociating proliferation and development of effector function. J Exp Med (2003) 3.21
Inflammatory cytokines provide a third signal for activation of naive CD4+ and CD8+ T cells. J Immunol (1999) 3.10
The roles of IL-12 in providing a third signal for clonal expansion of naive CD8 T cells. J Immunol (2002) 1.98
Does a positive lymphocyte cross-match contraindicate living-donor liver transplantation? Surgery (2010) 1.82
Apoptosis as a mechanism of cell death in liver allograft rejection. Transplantation (1995) 1.81
Peptide antigen priming of naive, but not memory, CD8 T cells requires a third signal that can be provided by IL-12. J Immunol (2002) 1.24
CD27 mediates interleukin-2-independent clonal expansion of the CD8+ T cell without effector differentiation. Proc Natl Acad Sci U S A (2006) 1.13
The use of mycophenolate mofetil in transplant recipients. Immunopharmacology (2000) 1.13
IL-12 priming during in vitro antigenic stimulation changes properties of CD8 T cells and increases generation of effector and memory cells. J Immunol (2004) 1.07
The rationale for the IL-2-independent generation of the self-renewing central memory CD8+ T cells. Immunol Rev (2006) 1.03
Pathways of memory CD8+ T-cell development. Eur J Immunol (2009) 1.00
A randomized, multicenter study comparing steroid-free immunosuppression and standard immunosuppression for liver transplant recipients with chronic hepatitis C. Liver Transpl (2011) 0.97
Basic concepts in transplant immunology. Liver Transpl (2005) 0.92
T-cell mediated induction of allogeneic endothelial cell chemokine expression. Transplantation (2003) 0.91
Initial steroid bolus injection promotes vigorous CD8+ alloreactive responses toward early graft acceptance immediately after liver transplantation in humans. Liver Transpl (2007) 0.89
Pharmacokinetics, efficacy, and safety of mycophenolate mofetil in combination with standard-dose or reduced-dose tacrolimus in liver transplant recipients. Liver Transpl (2009) 0.89
Liver transplantation: evolving patient selection criteria. Can J Gastroenterol (2001) 0.87
Clinical trial: switch to combined mycophenolate mofetil and minimal dose calcineurin inhibitor in stable liver transplant patients--assessment of renal and allograft function, cardiovascular risk factors and immune monitoring. Aliment Pharmacol Ther (2007) 0.86
Classification of human liver transplant recipients by their preoperative CD8+ T cell subpopulation and its relation to outcome. Liver Transpl (2006) 0.85
Apoptosis as a mechanism of tissue injury in liver allograft rejection. Semin Liver Dis (1998) 0.83
Serial assessment of immune status by circulating CD8 effector T cell frequencies for posttransplant infectious complications. Clin Dev Immunol (2008) 0.82
Coupled regulation of interleukin-12 receptor beta-1 of CD8+ central memory and CCR7-negative memory T cells in an early alloimmunity in liver transplant recipients. Clin Exp Immunol (2010) 0.80
Initial burst of viremia related to CD8 effector memory T cells after living donor liver transplantation in hepatitis C virus-infected recipients. Transl Res (2010) 0.79
Advantage of tacrolimus/mycophenolate mofetil regimen for cytotoxic T cell-mediated defence and its inhibition by additive steroid administration in high-risk liver transplant recipients. Clin Exp Immunol (2016) 0.75
Salvage living-donor liver transplantation for liver failure following definitive radiation therapy for recurrent hepatocellular carcinoma: a case report. Transplant Proc (2015) 0.75